Novanta Q2 Earnings Call Highlights

Novanta NASDAQ: NOVT reported second-quarter results marked by 9% organic sales growth, expanding margins and higher operating cash flow, while raising its full-year outlook following the late-July closing of its Riverpoint Medical acquisition.

MarketBeat • Aug 7, 2026

Novanta Inc. (NOVT) Q2 2026 Earnings Call Transcript

Novanta Inc. (NOVT) Q2 2026 Earnings Call Transcript

Seeking Alpha • Aug 6, 2026

Novanta Announces Financial Results for the Second Quarter 2026

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the second quarter 2026. Financial Highlights Three Months Ended   (In millions, except per share amounts) July 3,     June 27,     2026     2025   GAAP           Revenue $ 265.8     $ 241.0   Operating Income $ 18.1     $ 14.9   Net Income $ 12.5     $ 4.5   Diluted EPS $ 0.30     $ 0.12.

Business Wire • Aug 5, 2026

Novanta (NOVT) Tops Q2 Earnings and Revenue Estimates

Novanta (NOVT) came out with quarterly earnings of $0.89 per share, beating the Zacks Consensus Estimate of $0.83 per share. This compares to earnings of $0.76 per share a year ago.

Zacks Investment Research • Aug 5, 2026

Conestoga SMid Cap Composite Q2 2026 Portfolio Review

West Pharmaceuticals stock moved higher following another quarter of broad-based growth, driven by continued demand for high-value biologics packaging and proprietary delivery components. Tyler Technologies underperformed during the quarter despite delivering solid financial results that met management's guidance. We were attracted to Knowles' accelerating organic growth, expanding margins, and exposure to several attractive long-term secular trends.

Seeking Alpha • Jul 31, 2026

Will Novanta (NOVT) Beat Estimates Again in Its Next Earnings Report?

Novanta (NOVT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Investment Research • Jul 29, 2026

Novanta (NOVT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Novanta (NOVT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research • Jul 29, 2026

Conestoga Small Cap Composite Q2 2026 Portfolio Activity

DGII stock moved higher after the company reported record revenue and continued progress shifting toward a more recurring revenue-oriented business model. We remain encouraged by DSGX's mission-critical software, highly recurring revenue model, and disciplined capital allocation strategy, which continue to support our long-term investment thesis. We believe Kodiak Gas Services is well positioned to benefit from growing demand for natural gas infrastructure, LNG exports, and power generation supporting AI-related data center development.

Seeking Alpha • Jul 29, 2026

Novanta Completes Acquisition of Riverpoint Medical

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today announced that it has completed the acquisition of Riverpoint Medical (“Riverpoint Medical” or “Riverpoint”) from Arlington Capital Partners. Riverpoint is a category leader in high-growth minimally invasive surgical consumables, including advanced surgical fibers and related technologies for sports medicine, trauma and.

Business Wire • Jul 27, 2026

Novanta Inc. Announces Schedule of Second Quarter 2026 Earnings Release and Conference Call

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its second quarter 2026 results after the close of U.S. financial markets on Wednesday, August 5, 2026. The Company will host a conference call on Thursday, August 6, 2026, at 8:00 a.m. ET to discuss these results. To access the call, please dial (888) 346-3959 before the scheduled conference call time. Alternatively, the con.

Business Wire • Jul 14, 2026